Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 44Pancreatic Neoplasms 39Rectal Neoplasms 20Colonic Neoplasms 19Stomach Neoplasms 18Neoplasm Metastasis 16Esophageal Neoplasms 13Cholangiocarcinoma 13Barrett Esophagus 11Carcinoma, Hepatocellular 10Ovarian Neoplasms 9Breast Neoplasms 9Adenocarcinoma Of Esophagus 9Melanoma 8Anus Neoplasms 8Neoplasms 7Sarcoma 6Lung Neoplasms 6Liver Neoplasms 6Glioma 6Gastroesophageal Reflux 6Gallbladder Neoplasms 6Uterine Cervical Neoplasms 5Lymphoma, Non-Hodgkin 5Hepatoblastoma 5Esophageal Squamous Cell Carcinoma 5Endometrial Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Adenomatous Polyposis Coli 5Wilms Tumor 4

Interventions

tocotrienol, delta 2Surgical Procedures, Operative 2Paclitaxel 2Erlotinib Hydrochloride 2dehydroftorafur 1dachengqi decoction 1X-Rays 1Tomography, Optical Coherence 1Therapeutic Irrigation 1Surveys and Questionnaires 1Sulindac 1Specimen Handling 1Secretin 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Phantoms, Imaging 1Pancreatectomy 1Octreotide 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Immunohistochemistry 1Hydrocortisone 1Gemcitabine 1Fluorouracil 1Ferrosoferric Oxide 1Ethanol 1Endosonography 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Intraductal Neoplasms × Biopsy × Gastrointestinal × Clear all
NCT00482625 2014-10-16

Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Terminated
6 enrolled 8 charts
Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡